← All organizations

TWi Biotechnology, Inc.

For profitWebsite ↗

Also known as: TWi Biotechnology, Inc. | TWI PHARMS | TWI PHARMS INC

Highest phase reached

Phase 3

First clinical trial

Jan 1, 2011

First marketed drug

Jun 1, 2010

Last known activity

Jan 21, 2026

Timeline

1980s

  1. Jun 8, 1984

    chlorthalidone— NDA Secondary Org

2010s

  1. Jun 1, 2010

    TWi Biotechnology, Inc.— Founded

2020s

  1. Apr 1, 2022

    fluphenazine— Marketing Organization

Drugs by trial phase (6 distinct, 10 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (4 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Marketed drugs (33)

Recent trials (11)

Details

Founded
Taipei, TW Jun 1, 2010
Last known activity
Jan 21, 2026